These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 29708531)
21. Developmental effects of von Hippel-Lindau gene deficiency. Vortmeyer AO; Yuan Q; Lee YS; Zhuang Z; Oldfield EH Ann Neurol; 2004 May; 55(5):721-8. PubMed ID: 15122713 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas. Miyagami M; Katayama Y; Nakamura S Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918 [TBL] [Abstract][Full Text] [Related]
23. Molecular pathology of eyes with von Hippel-Lindau (VHL) Disease: a review. Chan CC; Collins AB; Chew EY Retina; 2007 Jan; 27(1):1-7. PubMed ID: 17218907 [TBL] [Abstract][Full Text] [Related]
24. An 11-bp duplication in the promoter region of the VHL gene in a patient with cerebellar hemangioblastoma and renal oncocytoma. Muscarella LA; Barbano R; Augello B; Formica V; Micale L; Zelante L; D'Agruma L; Merla G J Hum Genet; 2007; 52(6):485-491. PubMed ID: 17437055 [TBL] [Abstract][Full Text] [Related]
25. Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. Niemelä M; Lemeta S; Sainio M; Rauma S; Pukkala E; Kere J; Böhling T; Laatikainen L; Jääskeläinen J; Summanen P Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1909-15. PubMed ID: 10845616 [TBL] [Abstract][Full Text] [Related]
26. Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management. Catapano D; Muscarella LA; Guarnieri V; Zelante L; D'Angelo VA; D'Agruma L Neurosurgery; 2005 Jun; 56(6):1215-21; discussion 1221. PubMed ID: 15918937 [TBL] [Abstract][Full Text] [Related]
27. Study of angiogenic signaling pathways in hemangioblastoma. Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534 [TBL] [Abstract][Full Text] [Related]
28. Exploring the role of defective fibronectin matrix assembly in the VHL-associated CNS hemangioblastoma. Vikkath N; Ariyannur P; Menon KN; Mr B; Pillai A Drug Metab Pers Ther; 2018 Sep; 33(3):127-134. PubMed ID: 29813026 [No Abstract] [Full Text] [Related]
29. Case of parotid mucoepidermoid carcinoma: Expanding the spectrum of von Hippel-Lindau-related neoplasms. Berger MH; Kerr DA; Rangel Filho AE; Sargi ZB Head Neck; 2017 Mar; 39(3):E51-E54. PubMed ID: 28006088 [TBL] [Abstract][Full Text] [Related]
30. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma. Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424 [TBL] [Abstract][Full Text] [Related]
31. Clinical features of patients bearing central nervous system hemangioblastoma in von Hippel-Lindau disease. Kanno H; Kuratsu J; Nishikawa R; Mishima K; Natsume A; Wakabayashi T; Houkin K; Terasaka S; Shuin T Acta Neurochir (Wien); 2013 Jan; 155(1):1-7. PubMed ID: 23080552 [TBL] [Abstract][Full Text] [Related]
32. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis. Decker HJ; Weidt EJ; Brieger J Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583 [TBL] [Abstract][Full Text] [Related]
34. A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma. Fu XM; Zhao SL; Gui JC; Jiang YQ; Shen MN; Su DL; Gu BJ; Wang XQ; Ren QJ; Yin XD; Huang WB; Chen XG Genet Mol Res; 2015 May; 14(2):4513-20. PubMed ID: 25966224 [TBL] [Abstract][Full Text] [Related]
35. Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13. Beckner ME; Sasatomi E; Swalsky PA; Hamilton RL; Pollack IF; Finkelstein SD Hum Pathol; 2004 Sep; 35(9):1105-11. PubMed ID: 15343513 [TBL] [Abstract][Full Text] [Related]
36. Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Olschwang S; Richard S; Boisson C; Giraud S; Laurent-Puig P; Resche F; Thomas G Hum Mutat; 1998; 12(6):424-30. PubMed ID: 9829912 [TBL] [Abstract][Full Text] [Related]
37. Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas. Taïeb D; Barlier A; Yang C; Pertuit M; Tchoghandjian A; Rochette C; Zattara-Canoni H; Figarella-Branger D; Zhuang Z; Pacak K; Metellus P J Neurooncol; 2016 Feb; 126(3):473-81. PubMed ID: 26514359 [TBL] [Abstract][Full Text] [Related]
38. Von Hippel-Lindau disease germline mutations in Mexican patients with cerebellar hemangioblastoma. Rasmussen A; Nava-Salazar S; Yescas P; Alonso E; Revuelta R; Ortiz I; Canizales-Quinteros S; Tusié-Luna MT; López-López M J Neurosurg; 2006 Mar; 104(3):389-94. PubMed ID: 16572651 [TBL] [Abstract][Full Text] [Related]
39. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas. Heo SJ; Lee CK; Hahn KY; Kim G; Hur H; Choi SH; Han KS; Cho A; Jung M Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769 [TBL] [Abstract][Full Text] [Related]
40. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Kanno H; Kondo K; Ito S; Yamamoto I; Fujii S; Torigoe S; Sakai N; Hosaka M; Shuin T; Yao M Cancer Res; 1994 Sep; 54(18):4845-7. PubMed ID: 8069849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]